Sanofi to increase competition in atopic dermatitis market after Dupixent success

Submitted by admin on January 16, 2025 - 11:09am

Source:

Clinical Trials Arena

News Tags:

Headline:

snippet:

Within the atopic dermatitis (AD) field, Sanofi has been developing the IRAK4 degrader SAR444656 (KT-474) in collaboration with Kymera Therapeutics.

Search form